Licensed use — if any
No authorised human therapeutic indication is presented. In July 2026, an FDA advisory committee reviewed nominated BPC-157 bulk substances for ulcerative colitis compounding.
Preview openPlanned full launch in
--Days--Hrs--Min--Sec
← Peptide Intelligence
Experimental 15-amino-acid peptide
BPC-157
An experimental peptide widely promoted online for tissue and gastrointestinal recovery, despite the gap between preclinical research and proven human treatment.
Research interest
Preclinical models of gastrointestinal injury, inflammation and tissue repair. These models do not establish clinical effectiveness in people.
Evidence lens
Known does not mean proven for everything.
The strongest claim on the page should never be stronger than the strongest source behind it.
- The public evidence base is dominated by animal and laboratory work.
- FDA has assessed BPC-157-related bulk substances because of identified safety concerns.
- A product labelled 'research only' is not evidence of identity, sterility or human safety.
- Robust efficacy from well-controlled human trials.
- Long-term toxicity, immunogenicity and interaction profile.
- Whether online material contains the stated peptide at the stated purity.
- FDA highlights immunogenicity, aggregation and peptide-related impurity concerns.
- Safety information for proposed human routes is insufficient.
- Unapproved use can also create anti-doping and product-liability risk.
Regulatory snapshot
Jurisdiction and context matter.
No UK treatment claim is made. Verify the current medicines status with MHRA before any clinical presentation or supply.
Not FDA approved; FDA has identified significant safety concerns in the compounding review process.
BPC-157 is prohibited under WADA S0 as a non-approved substance.
Primary sources
Open the record.
Statuses change. Always check the current regulator, product label, trial record and anti-doping list.
Do not start, stop or source a medicine based on this page. Speak to a qualified healthcare professional and use regulated supply routes. Call 999 in an emergency or NHS 111 for urgent advice.
Continue through the library →